The global gastroesophageal reflux disease (GERD) device market is positioned for substantial growth over the next decade, with a projected market size of USD 1,207.3 million in 2024. According to recent market analysis, this growth is expected to continue at a compound annual growth rate (CAGR) of 3.6%, reaching an estimated market value of USD 1,719.5 million by 2034.

The increasing prevalence of GERD worldwide, alongside a growing preference for minimally invasive treatments, is fueling the demand for GERD devices. These innovative devices present a compelling alternative to traditional medication and surgery, offering patients long-term relief and improved management of the condition. As GERD becomes more common, particularly among aging populations, the adoption of these devices is expected to rise.

Technological advancements in device design are further driving market expansion. Improved durability, greater efficacy, and enhanced functionality of GERD devices are making them more attractive to both patients and healthcare providers. The evolution of these devices is helping to meet the increasing demand for effective treatment solutions, positioning them as a viable option in the management of GERD.

However, challenges such as stringent regulatory approval processes and restrictive reimbursement policies remain. Despite these obstacles, leading manufacturers in the GERD device sector are actively exploring strategic partnerships and driving product innovations to navigate these challenges and accelerate market growth.

With its promising growth prospects, the global GERD device market presents significant opportunities for both established industry leaders and emerging players, further strengthening the healthcare sector's response to the rising global burden of GERD.

Regional Outlook:

• The rise in the incidence of GERD in Asia Pacific stimulates demand for GERD devices, with lifestyle changes and food habits contributing to the increase.
• In Europe, digital health technology in GERD care is gaining traction, allowing for remote monitoring and increasing patient engagement in their treatment path.
• High healthcare spending and a well-established healthcare system in North America promote rapid developments in GERD device technology, emphasizing improving patient outcomes.

“Due to the increasing global prevalence of GERD, the gastroesophageal reflux disease (GERD) device market is expected to rise. Market expansion of GERD device is anticipated to be propelled by advancements in minimally invasive technologies and increasing demand for non-pharmacological treatment choices.”- opines Sabyasachi Ghosh Associate Vice President at Future Market Insights (FMI).

Enhanced Market Demand: Discover Thorough Trends and Insights in Our Complete Report! https://finance.yahoo.com/news/global-gastroesophageal-reflux-disease-gerd-114000520.html

Key Takeaways:

• In the product category, the esophagoscopes and gastroscopes segment to acquire a market share of 90% in 2024.
• The diagnostic procedures segment in the procedure category to grab a share of 68% in 2024.
• From 2024 to 2034, the India gastroesophageal reflux disease (GERD) device industry is projected to strengthen at a 5.2% CAGR.
• Thailand gastroesophageal reflux disease (GERD) device sales are expected to surge at a CAGR of 5.0% through 2034.
• Through 2034, the Indonesia GERD device market is expected to expand at a CAGR of 3.4%.
• Between 2024 and 2034, the Malaysia gastroesophageal reflux disease (GERD) device industry is projected to evolve at a CAGR of 4.6%.
• Through 2034, the United States gastroesophageal reflux disease (GERD) device market is expected to expand at a CAGR of 2.6%.
• Sales of gastroesophageal reflux disease (GERD) device in Canada are forecast to rise at a CAGR of 2.9% until 2034.
• The Spain GERD device market is expected to evolve at a CAGR of 2.9% between 2024 and 2034.
• The France gastroesophageal reflux disease (GERD) device market anticipates flourishing at a CAGR of 2.3% between 2024 and 2034.
• The Germany GERD device market is projected to exhibit growth between 2024 and 2034 at a CAGR of 1.9%.
• Sales of gastroesophageal reflux disease (GERD) device in Italy are expected to rise at a CAGR of 2.0% until 2034.
• The United Kingdom gastroesophageal reflux disease (GERD) device industry is expected to experience expansion at a CAGR of 1.6% through 2034.

Competitive Landscape:

Prominent gastroesophageal reflux disease (GERD) device providers continue strategically concentrating on joint ventures and the distribution expansion of diverse products. To improve the treatment of diseases, leading gastroesophageal reflux disease (GERD) device vendors for the condition focus on technological innovation.

Latest Developments:

• China approved Peptest, a non-invasive radiofrequency device developed by RD Biomed to diagnose reflux devices. The gadget aids in the general management of reflux-related gadgets and finds pepsin in saliva samples.
• The EsophyX Z gastroesophageal reflux disease device, used to conduct transoral incisionless fundoplication, is an upgraded and newer model of the EsophyX device.

Prominent Gastroesophageal Reflux Disease (GERD) Device Vendors:

• Olympus Corporation
• Pentax Medical
• KARL STORZ SE and Co KG.
• Medtronic Plc
• Fujifilm Holdings Corporation
• EndoGastric Solutions
• Medigus Ltd.
• Diversatek Inc.

Key Segments:

By Product:

• Diagnostic Devices
• Manometry Systems
• PH Monitoring Systems
• Esophagoscopes and Gastroscopes
• Treatment Devices
• Ultrasonic Surgical Endostaplers
• Fundoplication Devices
• Sphincter Augmentation Devices
• Radiofrequency Ablation Devices

By Procedure:

• Diagnostic Procedures
• Fundoplication Procedures
• Radiofrequency Thermal Ablation
• Magnetic Sphincter Augmentation

By End User:

• Hospitals
• Diagnostic Centers
• Ambulatory Surgical Centers

By Region:

• North America
• Latin America
• Europe
• East Asia
• South Asia and Pacific
• Middle East and Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube